Item | Information |
---|---|
CAS RN | 7580-67-8 |
Chemical Name | Lithium hydride |
Substance ID | m-nite-7580-67-8_v1 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | To Guidance List |
UN GHS document (External link) | To UN GHS document |
FAQ(GHS classification results by the Japanese Government) | To FAQ |
List of Information Sources (Excel file) | List of Information Sources |
List of Definitions/Abbreviations | Definitions/Abbreviations |
Sample Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Sample SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | To OECD/eChemPortal (External link) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Explosives | Not classified (Not applicable) |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecule. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
2 | Flammable gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
3 | Aerosols | Not classified (Not applicable) |
- |
- | - | Not aerosol products. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
4 | Oxidizing gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
5 | Gases under pressure | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
6 | Flammable liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
7 | Flammable solids | Classification not possible |
- |
- | - | It is written that it is flammable (ICSC(J) (2014)), but the classification is not possible due to no data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
8 | Self-reactive substances and mixtures | Not classified (Not applicable) |
- |
- | - | There are no chemical groups present in the molecule associated with explosive or self-reactive properties. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
9 | Pyrophoric liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
10 | Pyrophoric solids | Not classified |
- |
- | - | It is estimated that it does not ignite at normal temperatures from an autoignition temperature of 200 deg C (ICSC(J) (2014)). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
11 | Self-heating substances and mixtures | Classification not possible |
- |
- | - | No data available. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Category 1 |
Danger |
H260 | P302+P335+P334 P231+P232 P370+P378 P402+P404 P223 P280 P501 |
It is written that it reacts vigorously with water (ICSC(J) (2014)). Due to Division 4.3, PGI (UN1414) in UNRTDG, it was classified in Category 1. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
13 | Oxidizing liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
14 | Oxidizing solids | Not classified |
- |
- | - | It is written that it is a strong reducing agent and reacts vigorously with oxidants (ICSC(J) (2014)). | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
15 | Organic peroxides | Not classified (Not applicable) |
- |
- | - | It is an inorganic compound. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Test methods applicable to solid substances are not available. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
17 | Desensitized explosives | - |
- |
- | - | - | - | - |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. Additionally, although an LD50 value of 77.5 mg/kg (RTECS) for rats is reported, this information source is listed in List 3, and the original article is unknown. Therefore, it is not possible to classify only with this value. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
1 | Acute toxicity (Inhalation: Gases) | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
1 | Acute toxicity (Inhalation: Vapours) | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Category 3 |
Danger |
H331 | P304+P340 P403+P233 P261 P271 P311 P321 P405 P501 |
Two LC50 values (4hours) of 960 mg/m3 (converted value: 0.96 mg/L) (male and female) (ACGIH (7th, 2015)) and 1,800 mg/m3 (converted value: 1.80 mg/L) (male and female) (ACGIH (7th, 2015)) for rats are reported. One of these two corresponds to Category 3, and the other corresponds to Category 4. This substance was classified in Category 3 by adopting the category with higher hazard. Besides, the data (DFGOT Vol.3 (1991)) used for the previous classification was not adopted as the evidence of the classification because it did not specify an LC50 value. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
2 | Skin corrosion/irritation | Category 1 |
Danger |
H314 | P301+P330+P331 P303+P361+P353 P305+P351+P338 P304+P340 P260 P264 P280 P310 P321 P363 P405 P501 |
It is reported that it is a severe irritant to the skin (HSDB (Access on June 2016)), and it may be corrosive (ACGIH (7th, 2015)) in humans. Therefore, this substance was classified in Category 1. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
3 | Serious eye damage/eye irritation | Category 1 |
Danger |
H318 | P305+P351+P338 P280 P310 |
Because it is reported that it indicates severe eye irritation in humans (DFGOT (1992), HSDB (Access on June 2016)), this substance was classified in Category 1. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
4 | Skin sensitization | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
5 | Germ cell mutagenicity | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
6 | Carcinogenicity | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
7 | Reproductive toxicity | Category 1A, |
Danger |
H360 H362 |
P308+P313 P201 P202 P260 P263 P264 P270 P280 P405 P501 |
There is no information on the reproductive effects of this substance itself. However, this substance is rapidly hydrolyzed to produce lithium hydroxide (CAS RN 1310-66-3 (anhydride: 1310-65-2)), a strong alkali, on contact with water vapor and the mucous membrane (ACGIH (7th, 2015)). Therefore, it is considered that information on lithium salts is available for classification. In humans, an association between lithium dosing in pregnant women and cardiovascular anomalies, such as Ebstein's anomaly, was first reported in 1974. Ebstein's anomaly had since then been thought to occur at a high rate (400 times higher than spontaneous rate), but Cohen et al., reported that based on a reanalysis, the occurrence of Ebstein's anomaly was 2/1,000 live births compared to the spontaneous rate of 1/20,000 live births (Cohen L.S. et al.: JAMA, 271, 146 (1994)). It was indicated that lithium is a "weak" teratogen in humans (Giles J.J and Bannigan J.G.: Curr. Pharm. Des., 12, 1531 (2006)). Thereafter, up to 2016, Cohen et al.'s finding of 2/1,000 cases (0.2%) was cited as the occurrence rate of Ebstein's anomaly due to lithium treatment in pregnant women; and it has been cautioned that special attention, such as observations of high-resolution ultrasound and fetal echo-cardiography, is necessary with regard to pregnant women with bipolar disorder receiving lithium treatment (Khan S.J. et al.: Curr. Psychiatry Rep., 18, 13 (2016)). Also, according to an observational study from Israel in 2014, it was reported that cardiovascular anomalies in neonates occurred more frequently in the lithium-dosed group at 2.4% (5/123 cases) compared with the control group at 0.6% (4/711cases); and the occurrence of cardiovascular anomalies in the combined multicenter data of Australia and Canada was 0.5% (4/842 cases) for the control group and 3.9% (6/152 cases) for the lithium-dosed group (Diav-Cirtrin, O. et al.: Am. J. Psychiatry, 171, 785 (2014)). From the above, it is thought that the cardiovascular anomalies, including Ebstein's anomaly, are clearly considered to be the effect of lithium administration. Furthermore, as for lithium dosing in the first trimester of pregnancy, it is also reported that other signs of neonatal toxicity such as neuropathy, respiratory disturbances, floppy infant, hyperbilirubinemia, disturbance of the heart's rhythm, hypothyroidism, and diabetes insipidus were observed (Khan S.J. et al.: Curr. Psychiatry Rep., 18, 13 (2016)). As for experimental animals, when lithium carbonate was administered orally to pregnant rats from day 6-15 of gestation at 100 mg/kg, fetal toxicity (reduction in number of implantation and of the live fetus, increased trend in the number of embryo resorptions) and teratogenicity (wavy ribs, shortening of bones such as the humerus and the femur, malformations in the skull and pelvis, separation in the skull) were recognized (Marathe M.R. and Thomas G.P.: Toxicol. Lett., 34, 115. (1986)). Also, when lithium carbonate was administered intraperitoneally to pregnant female mice at doses ranging from 330 to 340 mg/kg on the ninth gestation day, induction of malformations such as exencephaly, cranioschisis, rachischisis, kinking of the spinal cord, and dilation of the fourth brain ventricle etc. were observed (Jurand A.: Teratology, 38 (2), 101. (1988)). On the other hand, there are several reports in which no developmental effects were observed by lithium administration to pregnant animals, but it is thought that this was due to differences in doses and the animal lineage (Giles, J.J. and Bannigan, J.G.: Curr. Pharm. Des., 12, 1531 (2006)). From the above, as for humans, it was reported that cardiovascular anomalies and various developmental effects occur from lithium dosing during pregnancy; as for experimental animals as well, there are reports of teratogenicity. Therefore, this substance was classified in Category 1 for this hazard class. Furthermore, in an examination until 52 weeks after post partum, the lithium levels in the breast milk and the neonatal serum were about half and one fourth of the maternal serum levels, respectively (Khan S.J. et al.: Curr. Psychiatry Rep., 18, 13 (2016)). In Japan, lithium (lithium carbonate) is contraindicated for women anticipating pregnancy, but when administration is inevitable, breast-feeding must be discontinued (Ethical Pharmaceuticals 2017 (2016)). Therefore, "additional category for effects on or via lactation" was added to the classification. |
FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
8 | Specific target organ toxicity - Single exposure | Category 1 (respiratory organs), Category 2 (nervous system) |
Danger Warning |
H370 H371 |
P308+P311 P260 P264 P270 P321 P405 P501 |
This substance is rapidly hydrolyzed to produce lithium hydroxide, a strong alkali, on contact with water vapor and the mucous membranes. It is described that lithium hydroxide causes intensely and immediately caustic damage in the nasal, oral, pharyngeal and respiratory mucosa, and can cause pulmonary edema (ACGIH (7th, 2015)). In addition, it is reported that in humans, nausea, muscle twitches, mental confusion, blurring of vision and coma are caused by accidental ingestion of this substance (HSDB (Access on June 2016)). Therefore, this substance was classified in Category 1 (respiratory organs), Category 2 (nervous system). Since HSDB is an information source listed in List 2, this substance was classified in Category 2 for the nervous system. |
FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
9 | Specific target organ toxicity - Repeated exposure | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
10 | Aspiration hazard | Classification not possible |
- |
- | - | Classification not possible due to lack of data. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment Short term (Acute) | Classification not possible |
- |
- | - | No data available. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
11 | Hazardous to the aquatic environment Long term (Chronic) | Classification not possible |
- |
- | - | No data available. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | No data available. | FY2016 | GHS Classification Guidance for the Japanese Government (FY2013 revised edition (Ver. 1.1)) |
|